Results 101 to 110 of about 40,504 (198)

Interaction and compatibility studies of efavirenz with pharmaceutical excipients

Journal of Excipients and Food Chemicals, 2016
Although excipients have traditionally been thought of as being inert, experience has shown that there can be interactions between excipients and drugs. Thus, knowledge of potential physical and chemical interactions can be very useful. The compatibility
Cinira Fandaruff, Andrea Mariela Araya-Sibaja, Rafael Nicolay Pereira, Silvia Lucia Cuffini, Carlos Eduardo Maduro de Campos, Cristiane Rodrigues Drago Hoffmeister, Helvécio Vinícius Antunes Rocha, Marco Antônio Segatto Silva   +7 more
doaj  

Efavirenz Intoxication Due to Slow Hepatic Metabolism [PDF]

, 2017
We describe a human immunodeficiency virus-positive woman who presented with severe psychosis while she was receiving therapy with efavirenz. Her plasma efavirenz level was excessively high.
Bleiber, G., Günthard, H. F., Hasse, B., Krause, M.   +3 more
core  

HUBUNGAN ANTARA PEMAKAIAN EFAVIRENZ DENGAN EFEK SAMPING NEUROPSIKIATRI PADA PASIEN HIV/AIDS : Studi Kasus di RSUP dr. Kariadi Semarang [PDF]

, 2015
Background: HIV/AIDS has been a global problem. Antiretroviral therapy is currently an effective therapy for HIV/AIDS. Efavirenz is an antiretroviral agent which commonly cause neuropsychiatric adverse events.
Ngestiningsih, Dwi, Salsabillah, Farah, Sofro, Muchlis Achsan Udji   +2 more
core  

Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel

AIDS Research and Treatment, 2017
This study assessed the effect of efavirenz mid-dose plasma concentrations on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among 49 HIV infected women coadministering ethinylestradiol/levonorgestrel, including 34 HIV ...
Grant Munkwase, Kuteesa R. Bisaso, Othman Kakaire, Sarah Nanzigu   +3 more
doaj   +1 more source

Hubungan Antara Pemakaian Efavirenz Dengan Efek Samping Neuropsikiatri Pada Pasien Hiv/aids [PDF]

, 2015
Background: HIV/AIDS has been a global problem. Antiretroviral therapy is currently an effective therapy for HIV/AIDS. Efavirenz is an antiretroviral agent which commonly cause neuropsychiatric adverse events.Aim: To investigate the association between ...
Chasani, S. (Shofa), Ngestiningsih, D. (Dwi), Salsabila, F. (Farah), Sofro, M. A. (Muchlis)   +3 more
core  

Optimization of solid phase extraction for simultaneous quantification of efavirenz and levonorgestrel in wastewater using HPLC

Frontiers in Environmental Science
This study aims to optimize the SPE parameters for purification and preconcentration of EFV and LVG to enable optimum detection and quantification by LC-20 Prominence High-Performance Liquid Chromatography (HPLC) system.
E. P. Munzhelele, W. B. Ayinde, W. M. Gitari, W. M. Gitari, R. Mudzielwana   +4 more
doaj   +1 more source

Preliminary Report on Patent Literature, Search Methodology and Patent Status of Medicines on the WHO EML 2009 [PDF]

, 2011
Over the past several decades the World Health Organization (WHO) has produced the Essential Medicines List (EML) to assist countries in deciding what medicines should be essential and available in National Essential Medicine Lists.1 WHO, through the ...
Cavicchi, Jon R., Kowalski, Stanley P.
core   +1 more source

Efavirenz

Reactions Weekly, 2006
europepmc   +5 more sources

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin

Acta Medica Indonesiana, 2016
Aim:to determine the effect of a rifampicin-containing tuberculosis regimen on efavirenz plasma concentrations and viral load in HIV/AIDS-Tuberculosis infection patients who received efavirenz-based antiretroviral therapy.
Nina Mariana, Purwantyastuti Purwantyastuti, Instiaty Instiaty, Adria Rusli   +3 more
doaj  

Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation. [PDF]

Ann Epidemiol
Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WD, Pisa PT, Murray EJ, Brennan AT, Maskew M.   +9 more
europepmc   +1 more source